 |
|
|
Before and After
Nasolabial Folds at Baseline, 6, and 12 Months Post-Injection
Actual patient from the clinical trial.
Actual patient from the clinical trial.
Actual patient from the clinical trial.
Actual patient from the clinical trial.
Actual patient from the clinical trial.
Actual patient from the clinical trial.
*Primary endpoint
**No 12-month control per protocol
Please see complete Instructions for Use for detailed information about safety and efficacy.
1Data on file. Artes Medical, Inc. U.S. Pre-Market Approval Application P020012, March 28, 2002.
|
|
|
|
|
|
|
